Combination of two long-acting bNAbs at ART initiation in SSA to test the hypothesis that, given with antiretroviral therapy upon HIV diagnosis, bNAbs against HIV will induce an immune response leading to durable suppression of the disease once antiretroviral therapy is discontinued